Related references
Note: Only part of the references are listed.Galectin-3 in diabetic patients
Giuseppe Pugliese et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
Serum galectin-3 levels in women with PCOS
H. Yilmaz et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2014)
Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart Failure Data From CORONA and COACH
A. Rogier van der Velde et al.
CIRCULATION-HEART FAILURE (2013)
Galectin-3 Deficiency Accelerates High-Fat Diet-Induced Obesity and Amplifies Inflammation in Adipose Tissue and Pancreatic Islets
Nada N. Pejnovic et al.
DIABETES (2013)
The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS)
C. C. Lee et al.
DIABETOLOGIA (2013)
Circulating galectin-3 in infections and non-infectious inflammatory diseases
J. ten Oever et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2013)
Galectin-3 deficiency protects pancreatic islet cells from cytokine-triggered apoptosis in vitro
Tamara Saksida et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Increased Adiposity, Dysregulated Glucose Metabolism and Systemic Inflammation in Galectin-3 KO Mice
Jingbo Pang et al.
PLOS ONE (2013)
Simultaneous determination of serum galectin-3 and-4 levels detects metastases in colorectal cancer patients
Hannah Barrow et al.
CELLULAR ONCOLOGY (2013)
The fibrosis marker galectin-3 and outcome in the general population
R. A. de Boer et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community
Jennifer E. Ho et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Serum C-reactive protein level and prediabetes in two Asian populations
C. Sabanayagam et al.
DIABETOLOGIA (2011)
Transcriptional analysis of the endothelial response to diabetes reveals a role for galectin-3
April L. Darrow et al.
PHYSIOLOGICAL GENOMICS (2011)
Serum Galectin-3 Is Elevated in Obesity and Negatively Correlates with Glycosylated Hemoglobin in Type 2 Diabetes
Johanna Weigert et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice
E. P. K. Mensah-Brown et al.
CLINICAL IMMUNOLOGY (2009)
Association between C-reactive protein and pre-diabetic status in a Chinese Han clinical population
Jie Lin et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis
C. C. Lee et al.
DIABETOLOGIA (2009)
The regulation of inflammation by galectin-3
Neil C. Henderson et al.
IMMUNOLOGICAL REVIEWS (2009)
Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients
Pierre Vereecken et al.
MELANOMA RESEARCH (2009)
Inflammation, insulin resistance, and diabetes-mendelian randomization using CRP haplotypes points upstream
Eric J. Brunner et al.
PLOS MEDICINE (2008)
A prospective study of inflammatory Cytokines and diabetes Mellitus in a multiethnic cohort of postmenopausal women
Simin Liu et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Sex differences in the prediction of type 2 diabetes by inflammatory markers - Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002
Barbara Thorand et al.
DIABETES CARE (2007)
Genetic variation, C-reactive protein levels, and incidence of diabetes
Abbas Dehghan et al.
DIABETES (2007)
Galectin-3 stimulates preadipocyte proliferation and is up-regulated in growing adipose tissue
Kohji Kiwaki et al.
OBESITY (2007)
Inflammation and metabolic disorders
Goekhan S. Hotamisligil
NATURE (2006)
Diabetes, hyperglycemia, and inflammation in older individuals - The health, aging and body composition study
Nathalie De Rekeneire et al.
DIABETES CARE (2006)
Immune-mediated β-cell destruction in vitro and in vivo -: A pivotal role for galectin-3
AE Karlsen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Relationship between C-reactive protein and glucose levels in community-dwelling subjects without diabetes - The Hisayama Study
Y Doi et al.
DIABETES CARE (2005)
Use and abuse of HOMA modeling
TM Wallace et al.
DIABETES CARE (2004)
Share Paper
